Thomas G. Ricks

Thomas G. Ricks, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Ovintiv Inc. and Faeth Therapeutics, Inc. Over a trading history stretching from 9 December 2021 to 5 December 2025, the count stands at 15 filings.

The open-market side counts 2 purchases for €117k alongside 3 sales for €2.0M. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 7 option exercises.

Most recently, on 8 December 2025, the filings show a transaction in Ovintiv Inc. The latest purchase dates back some time: it was published 1,656 days ago, on 6 April 2022. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.